Delivery Order SPE2DB20D2104-SPE2DB23FS51R
Award Date 3/7/23
Potential Completion Date 3/8/23
Potential Value $1.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,322.24 for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,034.37 for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5ml. The contract was awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and has an ultimate completion date of February 1, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,977.42 for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a completion date of January 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $7,677.94 for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a completion date of April 8, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,955.80 for the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 22, 2024. The contract is a firm fixed-price delivery order without any set-aside designations, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order for $6,234.18 to supply the medication Trulicity 0.75 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 8, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,814.68 firm-fixed-price delivery order is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,622.88 for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 28, 2022. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,306.26 for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 8, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $10,478.84 for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 19, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS51RDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,331.22 for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 8, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition.
Generated 2/27/25, 10:06 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/7/23 |